IN Brief:
- KWE Korea has obtained GDP certification for pharmaceutical warehousing at Pyeongtaek Logistics Center Terminal 3.
- The certified areas cover refrigerated and frozen storage, each offering approximately 500m² of space.
- The facility supports bonded warehouse operations, non-resident inventory, and high-value healthcare logistics.
Kintetsu World Express has strengthened its pharmaceutical logistics capability in South Korea after KWE Korea obtained Good Distribution Practice certification for refrigerated and frozen warehousing at Pyeongtaek Logistics Center Terminal 3.
The certification applies to pharmaceutical warehousing services inside the refrigerated and frozen areas of Terminal 3, a facility completed in October 2024. The certified operation is designed for products requiring strict temperature management, with approximately 500m² of refrigerated space and 500m² of frozen storage, equivalent to around 350 pallets in each zone.
The site is equipped with temperature control and monitoring systems, supported by backup power supply. Those systems are central to GDP compliance, where pharmaceutical handling depends on stable storage conditions, auditable data, controlled processes, and documented intervention when environmental conditions move outside specification.
The warehouse has also obtained bonded warehouse status, allowing non-resident inventory operations. That gives international pharmaceutical companies and distributors more flexibility in how products are held, cleared, and routed through South Korea, particularly where ownership, customs treatment, and regional replenishment need to be separated from immediate domestic sale.
KWE Korea has historically been strong in semiconductor logistics, but the latest certification pushes the business further into healthcare and other high-value-added sectors. The development also adds another node to KWE Group’s wider healthcare logistics network, which includes GDP and CEIV Pharma certifications across multiple countries.
South Korea’s position in healthcare, technology, and advanced manufacturing gives Pyeongtaek a useful role as a logistics location. Pharmaceutical, medtech, diagnostics, and temperature-sensitive healthcare products require more than standard warehouse capacity. The chain needs validated space, trained teams, customs flexibility, power resilience, and reliable onward distribution.
The wider healthcare logistics market is moving in the same direction. Kuehne+Nagel has recently expanded cold-chain capacity in India, covered in Kuehne+Nagel opens Hyderabad pharma cold-chain facility, while air freight programmes are also being shaped around medicine movement, as seen in Saudia Cargo and SFDA support pharma air freight. Monitoring technology is another part of the same shift, with Testo Saveris to show GxP monitoring at PSIP Basel underlining the role of continuous environmental visibility.
The pressure on pharma logistics providers now extends beyond physical capacity. Customers need facilities that combine temperature stability, customs flexibility, regulatory documentation, and resilience against power or system interruptions. Product loss carries a direct financial cost, but an uncontrolled chain of custody can create regulatory exposure across entire product batches.
KWE Korea’s Pyeongtaek certification adds controlled storage capacity as healthcare supply chains are being redesigned around regional resilience. Global pharma networks remain dependent on air freight and long-distance flows, but more companies are building validated buffers, regional inventory options, and higher-quality storage into their operating models. The result is a cold-chain market where warehouse infrastructure forms part of compliance strategy, not just storage planning.
